These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 28653044)
1. Neuroclinical Framework for the Role of Stress in Addiction. Kwako LE; Koob GF Chronic Stress (Thousand Oaks); 2017 Feb; 1():. PubMed ID: 28653044 [TBL] [Abstract][Full Text] [Related]
2. Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development. Koob GF Pharmacol Rev; 2021 Jan; 73(1):163-201. PubMed ID: 33318153 [TBL] [Abstract][Full Text] [Related]
3. Antireward, compulsivity, and addiction: seminal contributions of Dr. Athina Markou to motivational dysregulation in addiction. Koob GF Psychopharmacology (Berl); 2017 May; 234(9-10):1315-1332. PubMed ID: 28050629 [TBL] [Abstract][Full Text] [Related]
4. Addiction as a stress surfeit disorder. Koob GF; Buck CL; Cohen A; Edwards S; Park PE; Schlosburg JE; Schmeichel B; Vendruscolo LF; Wade CL; Whitfield TW; George O Neuropharmacology; 2014 Jan; 76 Pt B(0 0):370-82. PubMed ID: 23747571 [TBL] [Abstract][Full Text] [Related]
5. Addiction is a Reward Deficit and Stress Surfeit Disorder. Koob GF Front Psychiatry; 2013; 4():72. PubMed ID: 23914176 [TBL] [Abstract][Full Text] [Related]
6. Emerging pharmacotherapies for alcohol use disorder. Mason BJ Neuropharmacology; 2017 Aug; 122():244-253. PubMed ID: 28454983 [TBL] [Abstract][Full Text] [Related]
7. The dark side of emotion: the addiction perspective. Koob GF Eur J Pharmacol; 2015 Apr; 753():73-87. PubMed ID: 25583178 [TBL] [Abstract][Full Text] [Related]
8. The Addictions Neuroclinical Assessment Negative Emotionality Domain Among Treatment-Seekers with Alcohol Use Disorder: Construct Validity and Measurement Invariance. Votaw VR; Pearson MR; Stein E; Witkiewitz K Alcohol Clin Exp Res; 2020 Mar; 44(3):679-688. PubMed ID: 31957027 [TBL] [Abstract][Full Text] [Related]
11. Existing and Future Drugs for the Treatment of the Dark Side of Addiction. Koob GF; Mason BJ Annu Rev Pharmacol Toxicol; 2016; 56():299-322. PubMed ID: 26514207 [TBL] [Abstract][Full Text] [Related]
12. Alcohol use disorder and sleep disturbances: a feed-forward allostatic framework. Koob GF; Colrain IM Neuropsychopharmacology; 2020 Jan; 45(1):141-165. PubMed ID: 31234199 [TBL] [Abstract][Full Text] [Related]
13. Examining the validity of the addictions neuroclinical assessment domains in a crowdsourced sample of adults with current alcohol use. Votaw VR; Boness CL; Stein ER; Watts AL; Sher KJ; Witkiewitz K Exp Clin Psychopharmacol; 2024 Feb; 32(1):68-83. PubMed ID: 37227882 [TBL] [Abstract][Full Text] [Related]
14. Neurobiological mechanisms and related clinical treatment of addiction: a review. Fang Y; Sun Y; Liu Y; Liu T; Hao W; Liao Y Psychoradiology; 2022 Dec; 2(4):180-189. PubMed ID: 38665277 [TBL] [Abstract][Full Text] [Related]
15. Applying the Addictions Neuroclinical Assessment to derive neurofunctional domains in individuals who use methamphetamine. Nieto SJ; Ray LA Behav Brain Res; 2022 Jun; 427():113876. PubMed ID: 35378110 [TBL] [Abstract][Full Text] [Related]